January 8, 2020 NIAID Funding News
Read this full edition online at http://www.niaid.nih.gov/
Feature Articles
Highlight Preliminary Data in Your Application
When applying, you must assess whether or not your preliminary data are sufficient to convince reviewers that your project has a high likelihood of success. Reviewers use this information to evaluate both the merit of your proposed studies and your skills as a scientist.
Opportunities and Resources
NIAID will fund translational research and advancement of rapid point-of-care diagnostics that test for active viremic hepatitis C virus infections.
NIAID will award a cooperative agreement to support clinical research evaluating the safety and efficacy of methods that can induce the immune system to tolerate certain antigens for treating immune-mediated disorders.
Apply if your research may lead to preventive nucleic acid-based vaccine platforms that protect against seasonal or pandemic influenza.
In The News
NIAID's budget for fiscal year 2020 is $5.89 billion, an increase of 6.6 percent from $5.52 billion in fiscal year 2019.
NIH policy on human fetal tissue (HFT) research requires that applications and proposals involving HFT that fall within a fundable scoring range be assessed for policy compliance by an ethics advisory board.
NIH’s Advisory Committee to the Director (ACD) makes recommendations for program development, resource allocation, NIH administrative regulation and policy, and other specific or general aspects of NIH policy.
Advice Corner
NIAID program staff can alert you to application requirements that you must address before submission. Reach out 10 to 12 weeks before applying to give yourself adequate time to complete all requisite tasks.
Reader Questions
New Funding Opportunities
- CEIRR Influenza Data Processing and Communication Center
- 2020 NIAID Omnibus Broad Agency Announcement
- NOT-OD-20-054, Notice of Special Interest: Administrative Supplements To Promote Research Continuity and Retention of NIH Mentored Career Development (K) Award Recipients and Scholars
- NOT-OD-20-038, Notice of Special Interest: Administrative Supplement for Research on Bioethical Issues (Admin Supp, Clinical Trial Optional)
- RFA-AI-19-072, Novel Therapeutics Directed to Intracellular HIV Targets (R21, Clinical Trial Not Allowed)
- NOT-OD-20-025, Notice of Special Interest: NIH Research Project Grants on Down Syndrome (R01) for the INCLUDE (INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE) Project
Find other announcements at NIAID Opportunities & Announcements.
Send suggestions or comments to deaweb@niaid.nih.gov.
.png)
No hay comentarios:
Publicar un comentario